High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$22.8M
$22,819,771
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CORT
M
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
Other
2026-03-04
$178,244
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
Other
|
2026-03-04 | $178,244 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
10b5-1 SellΔOwn -78.7%
2026-03-04
$296,346
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
10b5-1 SellΔOwn -78.7%
|
2026-03-04 | $296,346 | S | Form 4 |
| CORT |
CORCEPT THERAPEUTICS INC
|
Director
Other
|
2026-02-24 | $388,000 | M | Form 4 |
|
CORT
M
CORCEPT THERAPEUTICS INC
Hunt Hazel
• Officer • Chief Scientific Officer
Other
2026-02-09
$582,000
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Scientific Officer
Other
|
2026-02-09 | $582,000 | M | Form 4 |
|
CORT
M
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
Other
2026-02-03
$433,000
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
Other
|
2026-02-03 | $433,000 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
10b5-1 SellΔOwn -94.2%
2026-02-03
$817,334
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
10b5-1 SellΔOwn -94.2%
|
2026-02-03 | $817,334 | S | Form 4 |
| CORT |
CORCEPT THERAPEUTICS INC
|
Director
Other
|
2026-01-27 | $1,608,700Largex5 | M | Form 4 |
|
CORT
M
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
Equity Compensation
2026-01-06
$433,000x2
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
Equity Compensation
|
2026-01-06 | $433,000x2 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
10b5-1 SellΔOwn -94.2%
2026-01-06
$703,656
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
10b5-1 SellΔOwn -94.2%
|
2026-01-06 | $703,656 | S | Form 4 |
|
CORT
M
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
Equity Compensation
2025-12-02
$433,000x2
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
Equity Compensation
|
2025-12-02 | $433,000x2 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
10b5-1 SellΔOwn -34.1%
2025-12-02
$1,601,526Largex2
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
10b5-1 SellΔOwn -34.1%
|
2025-12-02 | $1,601,526Largex2 | S | Form 4 |
| CORT |
CORCEPT THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-12-01 | $3,190,796Large | S | Form 4 |
|
CORT
M
CORCEPT THERAPEUTICS INC
Lyon Joseph Douglas
• Officer • See Remarks
Equity Compensation
2025-12-01
$67,800x2
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
Equity Compensation
|
2025-12-01 | $67,800x2 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Lyon Joseph Douglas
• Officer • See Remarks
10b5-1 SellΔOwn -32.7%
2025-12-01
$397,632
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
10b5-1 SellΔOwn -32.7%
|
2025-12-01 | $397,632 | S | Form 4 |
|
CORT
M
CORCEPT THERAPEUTICS INC
Maduck Sean
• Officer • See Remarks
Equity Compensation
2025-12-01
$165,400x2
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
Equity Compensation
|
2025-12-01 | $165,400x2 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Maduck Sean
• Officer • See Remarks
10b5-1 SellΔOwn -71.7%
2025-12-01
$1,590,490Large
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
10b5-1 SellΔOwn -71.7%
|
2025-12-01 | $1,590,490Large | S | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
Discretionary SellΔOwn -85.1%
2025-11-25
$364,070
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
Discretionary SellΔOwn -85.1%
|
2025-11-25 | $364,070 | S | Form 4 |
| CORT |
CORCEPT THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-05 | $2,152,105Largex3 | S | Form 4 |
|
CORT
M
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
Other
2025-11-05
$433,000
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
Other
|
2025-11-05 | $433,000 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
10b5-1 Sell
2025-11-05
$1,507,122Largex3
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
10b5-1 Sell
|
2025-11-05 | $1,507,122Largex3 | S | Form 4 |
| CORT |
CORCEPT THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-03 | $831,014 | S | Form 4 |
|
CORT
M
CORCEPT THERAPEUTICS INC
Lyon Joseph Douglas
• Officer • See Remarks
Other
2025-11-03
$67,800
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
Other
|
2025-11-03 | $67,800 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Lyon Joseph Douglas
• Officer • See Remarks
10b5-1 SellΔOwn -32.7%
2025-11-03
$368,244
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
10b5-1 SellΔOwn -32.7%
|
2025-11-03 | $368,244 | S | Form 4 |
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
Other
|
2025-11-03 | $165,400 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Maduck Sean
• Officer • See Remarks
10b5-1 SellΔOwn -71.7%
2025-11-03
$1,479,816Large
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
10b5-1 SellΔOwn -71.7%
|
2025-11-03 | $1,479,816Large | S | Form 4 |
| CORT |
CORCEPT THERAPEUTICS INC
|
Director
Other
|
2025-10-10 | $30,976 | M | Form 4 |
| CORT |
CORCEPT THERAPEUTICS INC
|
Director
10b5-1 Sell
|
2025-10-10 | $192,588 | S | Form 4 |
|
CORT
M
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
Other
2025-10-07
$433,000
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
Other
|
2025-10-07 | $433,000 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Guyer William
• Officer • Chief Development Officer
10b5-1 SellΔOwn -79.1%
2025-10-07
$1,798,782Large
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • Chief Development Officer
10b5-1 SellΔOwn -79.1%
|
2025-10-07 | $1,798,782Large | S | Form 4 |
| CORT |
CORCEPT THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-10-01 | $3,403,253Largex3 | S | Form 4 |
|
CORT
M
CORCEPT THERAPEUTICS INC
Lyon Joseph Douglas
• Officer • See Remarks
Other
2025-10-01
$67,800
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
Other
|
2025-10-01 | $67,800 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Lyon Joseph Douglas
• Officer • See Remarks
10b5-1 Sell
2025-10-01
$423,766x3
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-01 | $423,766x3 | S | Form 4 |
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
Other
|
2025-10-01 | $159,005x2 | M | Form 4 |
|
CORT
S
CORCEPT THERAPEUTICS INC
Maduck Sean
• Officer • See Remarks
10b5-1 Sell
2025-10-01
$1,701,232Largex3
|
||||||
| CORT |
CORCEPT THERAPEUTICS INC
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-01 | $1,701,232Largex3 | S | Form 4 |